Hypofractionated stereotactic radiotherapy in the treatment of metastases

Stereotactic body radiation therapy (SBRT) is well suited for the palliative treatment of metastases in the brain, liver, lungs and sometimes also in the bones.

Hypofractionated stereotactic radiotherapy effectively destroys local metastases. Radiotherapy is often given for metastases after chemotherapy to stabilise the disease. In this way, the disease can be controlled without further chemotherapy.

Oncologists in Finland have long been using hypofractionated stereotactic radiotherapy with great success. In the treatment of metastases, the patient may be given 1 to 5 hypofractionated high-dose radiotherapy doses depending on the size, location and previous treatment of the metastases.

SBRT is used for the treatment of urological and gynaecological cancers, lung, intestinal, liver and breast cancer, and for the treatment of metastases of other cancers. In certain cases, SBRT can also be used as primary treatment for cancer.

Read more

Published: 22.04.2021

PSA testing best method so far for early detection of prostate cancer – Pros and cons of PSA 

PSA testing has its pros and cons. Should you have a PSA test?

Read more
Published: 15.03.2021

New blood test for prostate cancer diagnostics

Docrates Cancer Center is first in Finland to start using a new blood test supporting PSA-testing in prostate cancer A...

Read more
Published: 16.11.2020

Your safety is the most important to us

Many cancer patients have several concerns when it comes to the coronavirus pandemic, e.g. how does the situation impact my...

Read more
Published: 13.09.2020

Cancer and Coronavirus – FAQ

The coronavirus is a concern among cancer patients. We listed the most common concerns and the answers to them.

Read more

Why come to Docrates Cancer Center?

  • Top cancer experts and effective treatments without delay even during epidemic.
  • Individual care. You have your own care team - your doctor and your nurse.
  • Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
  • Experience in treating international patients from over 60 countries. Multilingual personnel.
358 10 773 2010

Contact us!

Mon-Thu 8 am-6 pm, Fri 8 am-4 pm (GMT +2)